The results of this study indicate that β-asarone attenuates HG-stimulated NLRP3 inflammasome-mediated lytic cell death and inactivates NF-κB in ARPE-19 cells, indicating its potential to treat hyperglycemia-induced DR. The gene discussed is NFKB1; the disease is Hyperglycemia.